SPACInsider contributor Eric Weidemann this week compiled his three favorite potential SPAC targets holding valuable music copyright catalogs. We look at why they are compelling and why each could be a fit for a blank-check merger. ...READ MORE
Osiris Acquisition Corp. announced the pricing of its downsized $230 million IPO and its units are expected to begin trading on the NYSE under the symbol “OSI.U” Friday, May 41.
The new SPAC aims to combine with a highly recognizable consumer, retail, or leisure company that has loyal customers and has been disproportionately affected due to the impact of COVID. ...READ MORE
&
Speakers
Tim Donahue – CEO, Cerberus Telecom
Nick Robinson – Co-Chief Investment Officer, Cerberus Telecom
Michael Palmer – Co-Chief Investment Officer, Cerberus Telecom
Romil Bahl – President & CEO, KORE
Puneet Pamnani – CFO, KORE
Orion Biotech Opportunities Corp. announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIAU” Thursday, May 13.
The new SPAC aims to combine with a North American, European or Asian healthcare company with a biotech focus. ...READ MORE
